The human microbiome consists of a multitude of bacterial genera and species which continuously interact with one another and their host establishing a metabolic equilibrium. The dysbiosis can lead to the development of pathology, such as inflammatory bowel diseases. Sulfide-producing prokaryotes, including sulphatereducing bacteria (SRB) constituting different genera, including the Desulfovibrio, are commonly detected within the human microbiome recovered from fecal material or colonic biopsy samples. It has been proposed that SRB likely contribute to colonic pathology, for example ulcerative colitis (UC).
Introduction
Sulphate reducing bacteria (SRB) are a diverse group of anaerobic prokaryotes able to reduce sulphate to sulphide [1] . They are ubiquitous in aquatic and terrestrial environments, and in man-made systems [2] , and are associated with plants, animals and humans [3] . In humans, SRB are known colonizers of the intestine and have been implicated in several clinical and inflammatory conditions such as periodontitis, Pouchitis, metabolic syndrome and obesity [4] ; [5] [6] [7] [8] .
More than nine hundred bacterial species are known to colonize the human gut [9] . The delicate balance between pathogenicity and host-commensal bacterial mutualism is maintained with constant tolerance of bacterial antigens [10, 11] , [12] . It is well accepted that an imbalance in the number or composition of gut microbiota (known as dysbiosis) is associated with a vary inflammatory diseases [13] .. While some bacteria are used as probiotics in clinical studies [14] , others can be harmful if they break across the epithelial barrier [13, 15, 16] . It has been proposed that induction of apoptosis of epithelial cells is one mechanism whereby the bacteria can cause pathology [17] . Some bacteria may also secrete virulence factors that can destroy the mucus barrier, allowing direct contact between bacteria and the epithelium [10, 18] .
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) of multifactorial etiology, i.e., susceptibility genes combine with environmental factors to produce the diseased phenotype [19, 20] . Bacterial infection could be one of the environmental factors. Although the involvement of SRB in the initiation and/or maintenance of UC in both humans and animals has been proposed [21, 22] , the exact mechanism by which SRB could contribute to UC etiology remains unknown. The modificated environment may contribute to unproportional growth of SRB. Furthermore SRB are resistant to broad spectrum antibiotics [23] , what can facilitates the burst of these bacteria in condition of repeated antibiotic use. The main product of metabolic the activity of SRB, sulphide, is toxic for human cells as it can destroy the sulphate-bridges in the mucus layer, thus neutralizing the ability of mucus to protect the colon epithelium [24, 25] . The mesophilic Gram-negative species representing the Desulfovibrio genus are of interest among the SRB. It has been demonstrated that members of Desulfovibrio colonize surfaces of intestinal epithelial tissue of UC animals and are absent in healthy animals [26] . In human studies, it has been reported that, compared to healthy controls, the abundance of Desulfovibrio cells in UC patients are higher than in controls [21, [27] [28] [29] . Although the role of diet in the etiology of UC remains uncertain, evidence suggests that in UC patients, low-fat diets and insoluble oligosaccharides (prebiotics) could be beneficial [30] . A decrease in the level of anaerobic bacteria such as SRB has been observed in the microflora of the intestinal tract following the beneficial diet change [31] [32] [33] . It is also known that diets poor in sulphur containing-compounds are beneficial to UC patients [27] . While the numbers of SRB are similar for UC patients and healthy controls, differences were noted in the proliferative rates of bacterial colonies enriched from these samples [34] .
Other studies confirmed that samples from UC patients and healthy controls harbor the same level of SRB, but there are significant differences in the structure of the SRB community between the two groups [35] . Here we report that SRB of the Desulfovibrio genus can interact with the surface of human intestinal epithelial cells and induce their apoptosis.
Material and Methods

Human intestinal tissue samples
Specimens of intestinal mucosa were taken during colonoscopy from the proximal colon of 29 patients with chronic ulcerative colitis and 37 control individuals with noninflammatory conditions from the Department of Gastroenterology, Queen Alexandra
Hospital. Portsmouth, UK. The biopsy procedure is described elsewhere [36] . Ulcerative colitis was diagnosed based on clinical, endoscopic and histological findings; the clinical data of patients and controls are shown in the 
Intestinal cryo-sections and Immunostaining assay
Dot blotting assay
The bacterial cells were pelleted from the culture by centrifugation for 15 min at 13,000 rpm. The cells were then suspended in 1 ml of distilled water, disrupted by eight freezing and thawing cycles (-180 o C and +37 o C, respectively) and spun at 13,000 rpm for 15 min.
The supernatants were transferred into another set of tubes and the pellets were dissolved in 100 µl of distilled water. Nitro-cellulose membrane (Bio-Rad) was adjusted to a dot 
SRB interaction with human epithelial cells assay.
The human epithelial cells line HCT8 cells from ATCC were distributed on 24 wells culture plates with and without slides on each well and left to grow in RPMI medium for 24h, achieving a monolayer culture. D. indonesiensis and E. coli 2R/BP were grown on VMNI medium and centrifuged for 1 min at 12,000 rpm on Eppendorf refrigerated centrifuge. The bacteria were then resuspended on RPMI medium. The bacteria (2x10 5 cells in 100 µl of medium) were added on wells containing 2x10 4 cells in 300 µl of RPMI and let to interact for 1h at 37 o C. After that, the cells were washed, 2 ml of RPMI medium were added, and the cells were maintained in a CO 2 incubator at 37 o C for two additional hours. In some wells, epithelial cells were pre-incubated with 10 µg/ml of cytochalasin D, a phagocytosis inhibitor drug, for 30 min before the infection. At the end of the experiments, the cells were washed and the slides were prepared for immunostaining assay. The remaining cells which had grown directly on wells were released by treatment with PBS/EDTA 1mM for 10 min at 37 o C, collected on Falcon tube and processed for flow cytometry analysis.
Immunostaining assay
The cells attached to slides were processed for immunostaining using the same incubation steps with antibodies, but additionally incubated with DAPI for bacterial DNA and nucleus of epithelial cells staining. The cells were analyzed using Zeiss Axioplan (Zeiss, Germany) microscope coupled with Leica DC 200 image acquisition system (Leica, Cambridge, UK).
Flow cytometry analysis
For flow cytometry analysis, the cells were fixed on paraformaldehyde (PFA) 4% in PBS for 10 min at room temperature. The cells were then washed with PBS and incubated with 10% of calf serum in phosphate buffer saline PBS to block unspecific bindings, followed by sequential incubations for 30 min at room temperature with: 1) rabbit anti-D. 
Apoptosis assay using flow cytometry
The HCT8 human intestinal epithelial cells were infected or not with pure strain (D.
indonesiensis or E. coli 2R/BP or E. coli K12) or with mixed culture bacteria (D. 
indonesiensis + E. coli
TUNEL labelling
Terminal deoxythymidine transferase-mediated dUTP nick end labelling (TUNEL) staining was performed using an in situ cell death detection kit (Boehringer Mannheim; 
Statistical analysis
Statistical analysis was performed using the unpaired Students't-test. Values of P < 0.05
were considered significant. (Fig. 2) , both when D.
indonesiensis infected alone (Fig. 2e ) or in combination with E. coli 2R/BP (Fig. 2g) .
The E. coli 2R/BP strain was not labelled with the antibody against EPS of D.
indonesiensis (Fig. 2, d, h; shown by arrows).
The pure D. indonesiensis and E. coli 2R/BP strains induce apoptosis of human intestinal epithelial cells
The infected and uninfected HCT8 cells were analyzed for hypo-diploid cells by flow cytometer as described in Material and Methods. We found that D. indonesiensis and E.
coli BP individually induced apoptosis in HCT8 cells and that the combination had a larger effect than either of them separately (Fig. 3a) . Z-VAD treatment inhibited partially apoptosis induced by either strain of bacteria, suggesting that the apoptosis induced by either strain individually may require the activity of caspases, but treatment was not We then investigated whether the apoptosis of HCT8 cells induced by D. indonesiensis, E. coli BP or by the combination was specific or a general effect of other bacterial species. We observed that D. indonesiensis or E. coli BP separately or in combination induced apoptosis (5 ±1%, 29 ±2%, or 41 ±1% respectively), while another strain of E.
coli (E. coli K12) also induced a low level of apoptosis (5 ±0.6%) in HCT8 cells. But the combination of bacteria enriched with SRB extracted from mucosal biopsies of healthy subjects did not induce apoptosis (Fig. 4) . Conversely, the combination of bacteria 
Apoptosis in human intestinal epithelial biopsies from ulcerative colitis patients
We examined apoptosis in biopsies of epithelial tissue from patients (n=3) and healthy donors (n=3) by the TUNEL technique. We observed many apoptotic cells in samples from colitis patients (Fig. 6a and 6b) . No apoptotic cells were observed on slides from healthy donor samples. Using antibodies against EPS of SRB, we also identified SRB on samples from ulcerative colitis patients, where they were found in association with the surface of intestinal epithelia (Fig. 6c) . These results suggested that the epithelial barrier was broken in the patients and the colonic epithelium was infiltrated with SRB bacteria.
3.4.
Antibodies against EPS of D. indonesiensis discriminate between SRB isolated from ulcerative colitis patients and control samples
The polyclonal antibody against EPS of D. indonesiensis was used to recognize SRB in bacteria consortium isolated in biopsies from the intestinal mucosa of ulcerative colitis patients and control groups by the dot blotting assay. As shown in table 1, the antibody could recognize 81% of samples from human colon biopsies from patients with ulcerative colitis and only 20.8% of samples from the control groups.
These results were confirmed by the immunofluorescence technique, which showed SRB staining in bacteria consortium isolated in biopsies from intestinal mucosa of ulcerative colitis patients (Fig.7a and b) but not control samples ( Fig. 7c and d) . These results suggest that the antibody against EPS of D. indonesiensis can be used as an additional marker for differential recognition of SRB present on human colon biopsies with and without ulcerative colitis.
Discussion
Intestinal bacteria are believed to play a role in the pathogenesis of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease. Genetically engineered animal models have shown the importance of commensal bacteria in development of disease [38, 39] , antibacterial treatment could improve symptoms of IBD [40] , and some SRB are susceptible to drugs used in active treatment of UC patients [41] .
Inhibition of BRS-sulfide production by 5-aminosalicylic acid (5-ASA)-containing drugs has been proposed for therapy of UC patients [42] . There are also circumstantial and sometimes conflicting reports regarding the differences in SRB populations (strains, growth rate) and metabolic activity (expressed as sulphide production) in healthy and diseased specimens. Furthermore, most of the reported data were obtained from fecal samples [43, 44] , which do not necessarily provide a reliable readout for SRB infection in the colon.
We show here that SRB can interact with the human epithelial intestinal cell membrane and are cytotoxic for those cells. The apoptosis induced by SRB was significantly higher when the cells were co-infected with E. coli commensal bacteria, and these findings were confirmed when the SRB and E. coli were obtained from UC patients. The mechanism how SRB induces cytotoxity in human intestinal epithelial cells is not completed understood. Interesting the Hydrogen sulfide (H 2 S) that is produced by both SRB and E.
coli [45] , at higher concentrations is associated with inhibition of cellular bioenergetics and mitochondrial respiration, pro-oxidant effects, DNA damage, suppression of cell viability and promotion of cell necrosis and/or apoptosis [46] . Depending of cell type the H 2 S treatment increases cell death in human lung fibroblast or inhibits cell cycle progression in rat smooth muscle, oral epithelial cells and human colon cancer cells inhibiting cyclin dependent kinase [47] . Furthermore, the H 2 S at lower concentration can develop a beneficial effect protecting intestinal cancer Caco2 cells from TNF and IFN-γ induced cell death [48] .
Previous studies have suggested that cell wall products derived from the luminal bacteria of the colon could cause colitis in immunodeficient mice [49] , and that bacterial flagellin is a dominant antigen in IBD [50] . Besides, LPS of SRB was associated with microbiota inflammatory properties [51] while E. coli LPS induces increase in plasma H 2 S levels in mice during inflammation [52] , what prompted us to consider the LPS as an additional signalling molecule responsible for the SRB effects on intestinal epithelial cells. In addition, some probiotic bacteria can confer health benefits to the host by improving the microbial composition of the indigenous microflora in UC patients [53, 54] . In this direction the infection by Yersinia enterocolitica induces chronic bowel inflammation with dysbiosis favoring SRB proliferation and treatment using probiotics could prevent the microbiota alterations changes and inflammation showing the importance of dysbiosis of the gut microbiota for development of IBD [12] .
Finally, recently we described that germ-free mice colonization with Desulfovibrio indonesiensis or with a human SRB consortium (from patients with colitis), induced changes in colonic architecture with increased cell infiltration in the lamina própria, and upregulation of IL-17 and Treg profiles of cytokine production/cell activation in cells from mesenteric lymph nodes [55] . What favors the hypothesis of SRB involvement in initiation of IBD.
Conclusion
We propose that SRB could contribute to initiation of IBD, by impairing the barrier function of the intestine and/or impairing the healing response to local inflammation. 
Informed consent
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